Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma.

Attention deficit disorder (ADHD) is a complex biobehavioral phenotype which affects up to 8% of the general population and often impairs social, academic, and job performance. Its origins are heterogeneous, but a significant genetic component is suggested by family and twin studies. The murine strain, coloboma, displays a spontaneously hyperactive phenotype that is responsive to dextroamphetamine and has been proposed as a genetic model for ADHD. Coloboma is a semi-dominant mutation that is caused by a hemizygous deletion of the SNAP-25 and other genes on mouse chromosome 2q. To test the possibility that the human homolog of the mouse coloboma gene(s) could be responsible for ADHD, we have carried out linkage studies with polymorphic markers in the region syntenic to coloboma (20p11-p12). Five families in which the pattern of inheritance of ADHD appears to be autosomal dominant were studied. Segregation analysis of the traits studied suggested that the best fitting model was a sex-influenced, single gene, Mendelian pattern. Several genetic models were evaluated based on estimates of penetrance, phenocopy rate, and allele frequency derived from our patient population and those of other investigators. No significant linkage was detected between the disease locus and markers spanning this chromosome 20 interval.

[1]  N. Copeland,et al.  Deletion map of the coloboma (Cm) locus on mouse chromosome 2. , 1994, Genomics.

[2]  D. Pauls Behavioural disorders: lessons in linkage , 1993, Nature Genetics.

[3]  G. Gyapay,et al.  A second-generation linkage map of the human genome , 1992, Nature.

[4]  J. Benjamin,et al.  Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. , 1992, Archives of general psychiatry.

[5]  C. Kozak,et al.  Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2 , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  A. Shenker,et al.  The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology. , 1992, Advances in pediatrics.

[7]  H. Pincus,et al.  DSM-IV and new diagnostic categories: holding the line on proliferation. , 1992, The American journal of psychiatry.

[8]  Judith M. Rumsey,et al.  Cerebral glucose metabolism in adults with hyperactivity of childhood onset. , 1990 .

[9]  S. Faraone,et al.  Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  J. Ott Genetic linkage and complex diseases: A comment , 1990 .

[11]  M. Moser,et al.  The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. , 1990, Behavioral and neural biology.

[12]  J. Stevenson,et al.  A twin study of hyperactivity--II. The aetiological role of genes, family relationships and perinatal adversity. , 1989, Journal of child psychology and psychiatry, and allied disciplines.

[13]  J. Ott Computer-simulation methods in human linkage analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Weber,et al.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. , 1989, American journal of human genetics.

[15]  Hugh Gurling,et al.  Localization of a susceptibility locus for schizophrenia on chromosome 5 , 1988, Nature.

[16]  Phil A. Silva,et al.  DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. , 1987, Archives of general psychiatry.

[17]  J. Biederman,et al.  A family study of patients with attention deficit disorder and normal controls. , 1986, Journal of psychiatric research.

[18]  J. Ott,et al.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.

[19]  P. Wender,et al.  Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults. , 1985, Psychopharmacology bulletin.

[20]  M. Stewart,et al.  Psychiatric disorder in the parents of hyperactive boys and those with conduct disorder. , 1980, Journal of child psychology and psychiatry, and allied disciplines.

[21]  S. Knardahl,et al.  Open-field behavior of spontaneously hypertensive rats. , 1979, Behavioral and neural biology.

[22]  W. Shekim,et al.  Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine. , 1979, The American journal of psychiatry.

[23]  N. Lambert,et al.  Prevalence of hyperactivity in elementary school children as a function of social system definers. , 1978, The American journal of orthopsychiatry.

[24]  B. Shaywitz,et al.  Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. , 1976, Science.

[25]  H. Akaike A new look at the statistical model identification , 1974 .

[26]  E. Silbergeld,et al.  Lead-induced behavioral dysfunction: an animal model of hyperactivity. , 1974, Experimental neurology.

[27]  L. Willerman Activity level and hyperactivity in twins. , 1973, Child development.

[28]  D. Cantwell Psychiatric illness in the families of hyperactive children. , 1972, Archives of general psychiatry.

[29]  M. Stewart,et al.  A family study of the hyperactive child syndrome. , 1971, Biological psychiatry.